- Home
- ARWR
as 12-18-2024 11:31am EST
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
| Founded: | 2003 | Country: | United States |
| Employees: | 525 | City: | PASADENA |
| Market Cap: | 2.7B | IPO Year: | 1993 |
| Target Price: | $42.70 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.05 - $39.83 | Next Earning Date: | 02-04-2025 |
| Revenue: | $3,551,000 | Revenue Growth: | -98.52% |
| Revenue Growth (this year): | 4225.26% | Revenue Growth (next year): | 59.48% |
Latest Arrowhead Pharmaceuticals Inc. News
ARWR Breaking Stock News: Dive into ARWR Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
B. Riley Lowers Price Target on Arrowhead Pharmaceuticals to $51 From $55, Keeps Buy Rating
Business Wire
7 days ago
Arrowhead Pharmaceuticals Presents Interim Clinical Data on ARO-CFB for the Treatment of Complement Mediated Diseases
Argus Research
8 days ago
ARWR: Lowering target price to $22.00
Simply Wall St.
11 days ago
Shareholders in Arrowhead Pharmaceuticals (NASDAQ:ARWR) have lost 66%, as stock drops 9.3% this past week
Clinical Trials Arena
14 days ago
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment
Argus Research
15 days ago
ARWR: Raising target price to $23.00
MT Newswires
15 days ago
HC Wainwright Raises Price Target on Arrowhead Pharmaceuticals to $80 From $60, Keeps Buy Rating
MT Newswires
15 days ago
Arrowhead Pharmaceuticals Files Request to Initiate Phase 1/2a Trial of Obesity Treatment
Compare ARWR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARWR Arrowhead Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.